MAI Wealth Advisors »

Sinovac Biotech shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Sinovac Biotech shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Sinovac Biotech

Tip: Access up to 7 years of quarterly data

All positions including Sinovac Biotech held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sinovac Biotech by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 3 0.00
2025-06-30 $0 3 0.00

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Sinovac Biotech

Vivo Capital
OrbiMed Advisors
Renaissance Technologies
Neumann Advisory Hong Kong
CalPERS
Skandinaviska Enskilda Banken AB
Spark Investment Management
Geode Capital Management
Wells Fargo & Company
Susquehanna International
Navellier & Associates
Morgan Stanley
UBS Group
Advisor Group Holdings
Atlantic Edge Private Wealth Management

View all funds holding Sinovac Biotech